Bahamas vs Nauru: The number of people with susceptibility test result for rifampicin
Bahamas
12
in 2021
Nauru
14
in 2021
Bahamas rank
138th
Nauru rank
136th
The number of people with susceptibility test result for rifampicin over time
- Bahamas
- Nauru
How they compare
Nauru currently reports 14 against 12 in Bahamas, a difference of 2.
That makes Nauru's figure about 1.2 times Bahamas's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bahamas ahead.
Bahamas ranks 138th and Nauru ranks 136th of 155 countries.
Bahamas has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahamas | Nauru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.67 | 0 | 17.67 | Bahamas |
| 2020s | 16 | 7 | 9 | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahamas or Nauru?
- Nauru, at 14 against 12 in Bahamas as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahamas and Nauru?
- 2, with Nauru ahead.
- How many years of comparable data are there for Bahamas and Nauru?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahamas and Nauru rank globally for the number of people with susceptibility test result for rifampicin?
- Bahamas ranks 138th and Nauru ranks 136th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.